Insiders · Profile

REESE DAVID M

EVP & Chief Technology Officer at Amgen. Filing since 19 Feb 2025. CIK 0001748434

Company
Date
Role
Action
Shares
Amount
Of holding
21 Feb 2025
EVP & Chief Technology Officer
Sold at will
25,225
$7.68M
40.6%
19 Feb 2025
EVP & Chief Technology Officer
Sold at will
8,711
$2.55M
12.3%
2 decisions on file.